Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer.
Journal: Future oncology (London, England)
Published: February 15, 2024
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma.
Journal: Nature communications
Published: December 05, 2023
Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non-Small-Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 04, 2023
Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design.
Journal: Future oncology (London, England)
Published: December 17, 2021
A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer.
Journal: Cancer chemotherapy and pharmacology
Published: December 18, 2017
Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies.
Journal: Cancer
Published: December 14, 2015
Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 04, 2015
A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 29, 2015
Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours.
Journal: British journal of cancer
Published: January 28, 2015
A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 23, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026